Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Report 2017

世界の非アルコール性脂肪肝疾患(NAFLD)薬市場:販売動向2017

◆タイトル:Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Report 2017
◆商品コード:QYR70324115
◆調査・発行会社:QYResearch
◆発行日:2017年2月15日
◆ページ数:118
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、非アルコール性脂肪肝疾患(NAFLD)薬の世界市場について調査・分析し、非アルコール性脂肪肝疾患(NAFLD)薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、非アルコール性脂肪肝疾患(NAFLD)薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・非アルコール性脂肪肝疾患(NAFLD)薬市場概要
・非アルコール性脂肪肝疾患(NAFLD)薬のメーカー別販売量・メーカー別シェア
・非アルコール性脂肪肝疾患(NAFLD)薬の世界市場:種類別販売量・市場シェア
・非アルコール性脂肪肝疾患(NAFLD)薬の世界市場:用途別販売量・市場シェア
・非アルコール性脂肪肝疾患(NAFLD)薬の世界市場:地域別販売量・市場シェア
・非アルコール性脂肪肝疾患(NAFLD)薬のアメリカ市場規模
・非アルコール性脂肪肝疾患(NAFLD)薬の中国市場規模
・非アルコール性脂肪肝疾患(NAFLD)薬のヨーロッパ市場規模
・非アルコール性脂肪肝疾患(NAFLD)薬の日本市場規模
・非アルコール性脂肪肝疾患(NAFLD)薬の東南アジア市場規模
・非アルコール性脂肪肝疾患(NAFLD)薬のインド市場規模
・非アルコール性脂肪肝疾患(NAFLD)薬のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・非アルコール性脂肪肝疾患(NAFLD)薬のコスト分析・価格動向
・非アルコール性脂肪肝疾患(NAFLD)薬の産業チェーン(サプライチェーン分析)
・非アルコール性脂肪肝疾患(NAFLD)薬のマーケティング戦略・販売チャネル、流通業者
・非アルコール性脂肪肝疾患(NAFLD)薬市場への影響要因分析
・非アルコール性脂肪肝疾患(NAFLD)薬の世界市場予測
・非アルコール性脂肪肝疾患(NAFLD)薬のアメリカ市場予測
・非アルコール性脂肪肝疾患(NAFLD)薬の中国市場予測
・非アルコール性脂肪肝疾患(NAFLD)薬のヨーロッパ市場予測
・非アルコール性脂肪肝疾患(NAFLD)薬の日本市場予測
・非アルコール性脂肪肝疾患(NAFLD)薬の東南アジア市場予測
・非アルコール性脂肪肝疾患(NAFLD)薬のインド市場予測
・非アルコール性脂肪肝疾患(NAFLD)薬の種類別世界市場予測
・非アルコール性脂肪肝疾患(NAFLD)薬の用途別世界市場予測
...

Notes:Sales, means the sales volume of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Revenue, means the sales value of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

This report studies sales (consumption) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International
Tobira Therapeutics
Verva Pharmaceuticals
Zafgen

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in each application, can be divided into
Application 1
Application 2

【レポートの目次】

Table of Contents

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Report 2017
1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
1.1 Product Overview and Scope of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2 Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2.1 Type I
1.2.2 Type II
1.3 Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.3.1 Application 1
1.3.2 Application 2
1.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug (2012-2022)
1.5.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2022)
1.5.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)

2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Competition by Manufacturers, Type and Application
2.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competition by Manufacturers
2.1.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Share by Manufacturers (2012-2017)
2.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Type
2.2.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type (2012-2017)
2.2.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Regions
2.3.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Regions (2012-2017)
2.3.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Regions (2012-2017)
2.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume) by Application

3 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
3.1 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
3.1.1 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
3.1.2 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
3.1.3 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
3.2 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
3.3 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
3.4 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
4.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
4.1.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
4.1.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
4.1.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
4.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
4.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
4.4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

5 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
5.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
5.1.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
5.1.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
5.1.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
5.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
5.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
5.4 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

6 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
6.1 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
6.1.1 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
6.1.2 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
6.1.3 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
6.2 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
6.3 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
6.4 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
7 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
7.1.1 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
7.3 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
7.4 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
8 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
8.1 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
8.1.1 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
8.1.2 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
8.1.3 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
8.2 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
8.3 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
8.4 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

9 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturers Analysis
9.1 Conatus Pharmaceuticals
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Daewoong Pharmaceutical
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Galmed International
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Kyorin Pharmaceutical
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Metabolic Solutions Development
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Novartis AG
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Phenex Pharmaceuticals
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Raptor Pharmaceuticals
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 TCM Biotech International
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Tobira Therapeutics
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Verva Pharmaceuticals
9.12 Zafgen

10 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Maufacturing Cost Analysis
10.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
10.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Forecast (2017-2022)
14.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price and Trend Forecast (2017-2022)
14.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Global Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Global Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)
Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2022)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales of Key Manufacturers (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers (2012-2017)
Figure 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers
Figure 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue by Manufacturers (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table 2016 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Growth Rate by Type (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Growth Rate by Type (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Regions (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Regions (2012-2017)
Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Growth Rate by Regions (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Regions (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Growth Rate by Regions (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Growth Rate by Application (2012-2017)
Figure United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2012-2017)
Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)
Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2012-2017)
Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)
Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2012-2017)
Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2012-2017)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2012-2017)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2012-2017)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)
Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2012-2017)
Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)
Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2012-2017)
Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)
Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2012-2017)
Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)
Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2012-2017)
Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)
Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2012-2017)
Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)
Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2012-2017)
Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)
Table Conatus Pharmaceuticals Basic Information List
Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Daewoong Pharmaceutical Basic Information List
Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Galmed International Basic Information List
Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Kyorin Pharmaceutical Basic Information List
Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Metabolic Solutions Development Basic Information List
Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Phenex Pharmaceuticals Basic Information List
Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table TCM Biotech International Basic Information List
Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Tobira Therapeutics Basic Information List
Table Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Verva Pharmaceuticals Basic Information List
Table Zafgen Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
Table Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
Table Major Buyers of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Distributors/Traders List
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2022)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2022)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Regions (2017-2022)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Type (2017-2022)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Application (2017-2022)



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の非アルコール性脂肪肝疾患(NAFLD)薬市場:販売動向2017] (Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Report 2017 / QYR70324115)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆